Skip to main content
All lobbying clients

ABBVIE, INC.

Lobbying client · District of Columbia · filed 2025 to 2026

Biopharmaceutical Research & Development Company.

$14,080,000 Reported spend
80 Filings counted
12 Outside firms hired
12 Bills named

Spend is reported income plus in-house expenses across 80 filings. 2 further filings for this client were restated by a later amendment and are left out of every total here. The LDA keeps a separate client record for every registrant that files for a client, so this page adds up 13 records, one per registrant listed below. Records are combined when the client name matches once case, punctuation and endings such as Inc. or LLC are set aside; for a city, county or port the state has to match as well. These filings have also been reported as ABBVIE, ABBVIE INC.

 Who filed for this client 13

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

 Bills named in these filings 12
  • H.R. 1
    One Big Beautiful Bill Act
    11 filings
  • S. 864
    HELP Copays Act
    10 filings
  • H.R. 1328
    Supply Chain Security and Growth Act of 2025
    7 filings
  • H.R. 1990
    American Innovation and R&D Competitiveness Act of 2025
    7 filings
  • H.R. 4299
    Protecting Patient Access to Cancer and Complex Therapies Act
    7 filings
  • H.R. 5376
    Impacts and Outcomes for Health Career Training Act
    7 filings
  • S. 1040
    Drug Competition Enhancement Act
    6 filings
  • H.R. 830
    HELP Copays Act
    3 filings
  • H.R. 5509
    Safe Step Act
    3 filings
  • S. 2903
    Safe Step Act
    3 filings
  • H.R. 8630
    PEAT Act of 2026
    1 filing
  • S. 1096
    Preserve Access to Affordable Generics and Biosimilars Act
    1 filing
 Reported by year 2 years
  • 2026 $6,390,000 40 filings
  • 2025 $7,690,000 40 filings
 Issues lobbied 11

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 13
  • HOUSE OF REPRESENTATIVES 63
  • SENATE 60
  • Centers For Medicare and Medicaid Services (CMS) 16
  • Commerce, Dept of (DOC) 16
  • Treasury, Dept of 15
  • U.S. Trade Representative (USTR) 15
  • Health & Human Services, Dept of (HHS) 11
  • White House Office 10
  • Executive Office of the President (EOP) 7
  • Patent & Trademark Office (PTO) 4
  • Food & Drug Administration (FDA) 3
  • Office of Management & Budget (OMB) 2
  • Natl Economic Council (NEC) 1
 Recent filings 82 total
Q3 report
FEDERAL STREET STRATEGIES, LLC
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $50,000 income · posted Oct 20, 2026
View →
Q3 report
MARSHALL & POPP, LLC
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $60,000 income · posted Oct 20, 2026
View →
Q3 report
WILLIAMS AND JENSEN, PLLC
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $90,000 income · posted Oct 20, 2026
View →
Q3 report
ABBVIE, INC.
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $1,050,000 expenses · posted Oct 20, 2026
View →
Q3 report
W STRATEGIES, LLC
3rd Quarter 2026 (July 1 - Sep 30) · House · $50,000 income · posted Oct 20, 2026
View →
Q3 report
TARPLIN, DOWNS & YOUNG, LLC
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $60,000 income · posted Oct 20, 2026
View →
Q3 report
ACG ADVOCACY
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $60,000 income · posted Oct 20, 2026
View →
Q3 report
TIBER CREEK GROUP
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $30,000 income · posted Oct 19, 2026
View →
Q3 reportNo activity
BAKER & HOSTETLER LLP
3rd Quarter 2026 (July 1 - Sep 30) · posted Oct 19, 2026
View →
Q3 report
BROWNSTEIN HYATT FARBER SCHRECK, LLP
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $90,000 income · posted Oct 19, 2026
View →
Q2 amendment
WILLIAMS AND JENSEN, PLLC
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $90,000 income · posted Oct 19, 2026
View →
Q3 report
CHECKMATE GOVERNMENT RELATIONS
3rd Quarter 2026 (July 1 - Sep 30) · $90,000 income · posted Oct 18, 2026
View →
Q3 report
CAPITOL TAX PARTNERS, LLP
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $80,000 income · posted Oct 16, 2026
View →
Q3 report
CORNERSTONE GOVERNMENT AFFAIRS, INC.
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $80,000 income · posted Oct 15, 2026
View →
Registration amendment
TIBER CREEK GROUP
3rd Quarter 2026 (July 1 - Sep 30) · posted Oct 8, 2026
View →
Q2 report
FEDERAL STREET STRATEGIES, LLC
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $50,000 income · posted Jul 20, 2026
View →
Q2 report
TARPLIN, DOWNS & YOUNG, LLC
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $60,000 income · posted Jul 20, 2026
View →
Q2 report
ABBVIE, INC.
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $1,160,000 expenses · posted Jul 20, 2026
View →
Q2 report
ACG ADVOCACY
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $60,000 income · posted Jul 20, 2026
View →
Q2 report
WILLIAMS AND JENSEN, PLLC Amended
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $30,000 income · posted Jul 20, 2026
View →

Showing the 20 most recent of 82 filings. Search the explorer for "ABBVIE, INC.".

Filings through , the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem